Clinical trials
Observational Amyotrophic Lateral Sclerosis trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Completed | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Istituto Auxologico Italiano | 6 |
| Neuromed IRCCS | 3 |
| Fondazione Don Carlo Gnocchi ETS | 2 |
| Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| Casa di Cura San Raffaele Cassino | 1 |
| IRCCS San Raffaele | 1 |
| Istituti Clinici Scientifici Maugeri SpA | 1 |
| Massachusetts General Hospital | 1 |
| Ospedale Policlinico San Martino | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 20 |
| Alzheimer Disease | 5 |
| Parkinson Disease | 5 |
| Motor Neuron Disease | 3 |
| Frontotemporal Dementia | 2 |
| Lewy Body Disease | 2 |
| Nerve Degeneration | 2 |
| Neurodegenerative Diseases | 2 |
| Bulbar Palsy, Progressive | 1 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.